Zobrazeno 1 - 3
of 3
pro vyhledávání: '"H. M. Da Silveira DE Carvalho"'
Autor:
R. Chakr, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, I. Pereira, H. De Leon de Lima, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. Silveira, S. Schowalski, D. Titton, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:596.2-597
BackgroundThe effect of age on persistence and safety of treatment with biologic disease modifying anti-rheumatic drugs (bDMARDs) in rheumatoid arthritis has been a subject to research interest. Two recently published studies did not observe signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db6af5613ed73ce4ed7201a921fa6faa
https://doi.org/10.1136/annrheumdis-2022-eular.2706
https://doi.org/10.1136/annrheumdis-2022-eular.2706
Autor:
M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:360.2-361
BackgroundAntimalarials (AM) are frequently part of the initial scheme of conventional synthetic DMARDs in the treatment of rheumatoid arthritis (RA), and have been associated with lower incidence of diabetes and better lipid profile in these patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ceb18110f322c04db0a32d4ddf73805
https://doi.org/10.1136/annrheumdis-2022-eular.4120
https://doi.org/10.1136/annrheumdis-2022-eular.4120
Autor:
S. M M de Souza, A. C. Medeiros-Ribeiro, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier
Publikováno v:
Annals of the Rheumatic Diseases. 81:1701.3-1702
BackgroundThe SARS-CoV-2 virus has caused a worldwide health crisis. Patients with inflammatory arthritis are at higher risk of hospitalization and death by COVID-19 due to comorbidities or immunosuppressive treatments. Vaccination is one the most im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9870f5ed931b4376d32fb010ace9fcd
https://doi.org/10.1136/annrheumdis-2022-eular.4722
https://doi.org/10.1136/annrheumdis-2022-eular.4722